BioSpace News Archive

OPTI Medical Systems, Inc., a subsidiary of IDEXX Laboratories, Inc., announced that it has received the CE mark certification in the European Union for its OPTI® SARS-CoV-2 RT-PCR laboratory test kit for the detection of SARS-CoV-2, the virus that causes COVID-19.

The sessions may be accessed from the “Investors & Media” page of Regeneron’s website at http://investor.regeneron.com/events-and-presentations.

Ionis Pharmaceuticals, Inc., the leader in antisense therapeutics, announced that management will present a company overview at the following virtual investor conferences

Abiomed announces the United States Food and Drug Administration has approved the company’s investigational device exemption application to start an early feasibility study with a first-in-human trial of the 9 French Impella ECP™ heart pump.

All pre-specified subgroup analyses in the pivotal trial favored voclosporin over placebo

Acacia Research Corporation, a publicly-traded investor in absolute return assets, announced that it had entered into an agreement with Link Fund Solutions Limited to purchase shares in up to 19 public and private life sciences companies from LF Equity Income Fund for a total consideration of up to £223.9 million.

Transparency Market Research has published a new report titled, “Bronchitis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

Transparency Market Research has published a new report titled, “Allergy relieving Eye Drops Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026”.

Transparency Market Research has published a new report titled, “Acute Lymphoblastic Leukemia Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

The global pharmaceutical analytical testing services market is poised to soar owing to the rising demand from pharmaceutical manufacturers and raw material suppliers.